Answers
Over 120
Total tumour caseload in the past 12 months
Answer Choices
What % of discussed patients were newly diagnosed (within the last 12 months)?
Please specify any discipline(s) not listed above and indicate how frequently they attend the MDT.
0-60 96
Total number of patients discussed at the MDT in the past 12 months 331 31771 Q27. Please select the clinical specialties that are involved in the MDT meetings and how frequently they attend the MDT 
Q5:
Which of the following patient groups are referred to the MDT?
MDT 10 responses showed a higher % of 'suspected cases' but lower % of 'patients diagnosed with relevant cancer ' . 
Q6: At which point/s along the treatment pathway is patient management discussed by the MDT?
All MDT 10 respondents agreed that the MDT is utilised for determination of treatment (100%), followed closely by initial diagnosis/referral (93%). While fewer members believed that follow up care (36%) and end of life care (29%) were discussed in the MDT the results were still above those for SWCN (29% vs 9%). Are patients informed that they will be discussed by the MDT? 57 64
Initial diagnosis and referral

Determination of treatment
Is patient consent (verbal or written) obtained for discussion of their case by the MDT?
38 64
Are patient preferences incorporated into the MDT discussion?
61 78
Is there a formal process for raising patient preferences in the MDT discussion? 15 14
Q37: % Respondents answering usually or always to the following questions
MDT 10 responses indicate that supportive care needs were a higher priority than SWCN overall (50% vs 28% and 50% vs 35%).
There was still a low referral rate to psychooncology and allied health services.
SWC N (117) MDT 10 (14)
How often are patients' supportive care needs (e.g., social, financial, psychological, or other needs) discussed in MDT meetings?
50
How often do supportive care needs of patients influence recommendations for treatment?
Do MDT discussions result in referrals to psycho-oncology services? 
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